Regulation of Calcium and Phosphate Homeostasis I Flashcards
In a healthy adult, bone deposition approximates
Bone reabsorption
Bone must be strong and rigid, yet somewhat flexible. These characteristics are conferred by the mix of
- ) Cortical Bone (80%)
2. ) Trabeculated bone (20%)
Comprises the outer layer of all bones and the bulk of the interior of long bones
Cortical bone
Dense tissue that gives bone it’s strength and shape
Cortical Bone
Contains bone mineral, extracellular matrix, blood vessels, and canaliculi
Cortical Bone
Comprises the interior of bones and is especially prominent in the vertebral bodies
Trabecular bone
Which undergoes more remodeling, trabecular or cortical bone?
Trabecular
The rigidity of bone comes from its organic matrix, which is comprised of
- ) Collagen (90-95%)
2. ) Ground substance
A mixture of extracellular fluid and proteoglycans (hyaluronic acid and chondroitin sulfate)
Ground substance
The storage form of bone salts Ca2+ and PO4
Hydroxyapatite
Exist in supersaturating conditions within the ECF
Ca2+ and PO4
Under normal circumstances, precipitation of Ca2+ and PO4 is prevented in all tissues except bone by
Pyrophosphate
The freeing of Ca2+ and PO4 from bone
Reabsorption
The use of Ca2+ and PO4 to lay down new bone
Deposition
The cell type responsible for reabsorption of bone
Osteoclasts
The cell type that controls deposition of bone
Osteoblasts
Mediate various components of deposition and reabsorption
Osteocytes
Large multinucleate cells which are concentrated around the growth surfaces of bone
Osteoclasts
At any given moment, less than 1% of the surface of adult bone is undergoing
Reabsorption
To begin reabsorption, osteoclasts secrete acids such as citric and lactic acid which
Dissolves bone mineral
Osteoclasts also secrete a substance to hydrolyze the organic matrix proteins, this is called
Proteolytic enzyme
Micro particles of the bone matrix are then phagocytosed by
Osteoclasts
Secrete factors that promote proliferation of osteoclast precursor cells
Osteoblasts
What do osteoblasts produce that stimulates the differentiation of proteoclasts into osteoclasts
Receptor Activator for Nuclea Factor kB (RANK) ligand (RANKL)
Also functions to upregulate osteoclast activity
RANKL
Binds RANKL and lowers the local availability
-also produced by osteoblasts
Osteoprotegerin
Orchestrate aspects of bone reabsorption and deposition, illustrating that mineralization of bone in the adult depends on reabsorption
Osteoblasts
Communicate with one another, bone surface, and bone marrow via dendritic processes
-Derived from osteoblasts
Osteocytes
Shear stress is sensed by the dendritic processes of osteocytes and in response, osteocytes orchestrate cycles of
Reabsorption and deposition
Plasma Ca2+ levels are maintained by the concerted actions of
PTH and Calcitriol
PTH and calcitriol maintain plasma Ca2+ levels within a relatively narrow range of
9.0-10.3 mg/dL
Of this, approximately 45% s circulating as
Ionized Ca2+
It is this ionized form which is
Bioavailable
The majority of total plasma Ca2+ is bound to
Albumin
More bioavailable Ca2+ is actually present than the measured amount would indicate with
Hypoalbuminemia
We can compensate for this phenomenon with hypoalbuminemia by raising the plasma Ca2+ by
0.8 mg/dL per 1.0g/dL drop in albumin
Approximately 85% of PO4 is stored in bone with around 14% in cells and about 1% in
Serum and ECF
Serum PO4 is maintained within a narrow range of approximately
2.0-3.5 mg/dL
Serum PO4 is regulated by the actions of PTH, calcitriol, and
Fibroblast growth factor 23
Secreted by the chief cells located within the parathyroid glands
PTH
Causes an increase in serum Ca2+ and a decrease in serum PO4
PTH
Recall that within the kidney, PTH suppresses the excretion of Ca2+ in urine, while increasing the excretion of PO4. These actions occur mainly in the
Distal tubules and collecting ducts
PTH promotes the synthesis of calcitriol by increasing renal
1a hydroxylase (CYP27B1)
Occurs during episodes of chronic elevation of PTH
-through an indirect mechanism involving osteoblasts
Bone reabsorption
Osteoblasts express
-Osteoclasts DO NOT
PTH receptors
As a result of chronic exposure to PTH such as would occur during the condition of hyperparathyroidism, osteoblasts secrete which 2 things?
- ) Protease which digests the bone matrix
2. ) Cytokines which promote osteoclasts differentiation and activity
Impairs collagen synthesis by osteocytes
PTH
Causes both a rapid and slow phase of Ca2+ and PO4 absorption
PTH
The rapid phase of Ca2+ and PO4 absorption which involves the removal of hydroxyapatite from the bone matrix and bone surface
Osteolysis
Within these regions of bone tissue, PTH has been shown to activate Ca2+ pumps that can mediate
Ca2+ absorption from bone
Osteolysis co-dependent on
Calcitriol
The slow phase of Ca2+ and PO4 absorption is mediated by
Osteoclasts and the interactions between osteoclasts and osteoblasts
Involved in the enzymatic digestion of bone matrix and the subsequent freeing of Ca2+
Osteoclasts
Increases osteoblast proliferation, blocks the onset of apoptosis in osteoblasts, and up-regulates Ca2+ channel activity in osteocytes
Acute elevations in PTH
Upregulation of Ca2+ channel activity in osteocytes allows for the intracellular transfer of Ca2+ from osteocytes to
Osteoblasts
Osteoblasts then pump this Ca2+ into the bone matrix enabling
Deposition
This knowledge is clinically useful in that human recombinant PTH and PTH-related peptide (PTHrp) can be used to promote
Bone mineralization
Parathyroid chief cells express
Calcium sensing receptors (CaSR)
These plasma membrane receptors are coupled to a number of intracellular signaling cascades which collectively control the synthesis and secretion of
PTH as well as chief cell proliferation
In the presence of normal or elevated plasma Ca2+ concentrations, CaSR tonically impair
PTH secretion and parathyroid cell proliferation
When the extracellular Ca2+ concentration falls, change in CaSR-mediated signaling trigger the production and release of
PTH
Note tht inactivating CaSR mutations induce
Chief cell hyperplasia and elevated PTH secretion
Is also coupled to upregulating vitamin D receptor (VDR) expression in chief cells
CaSR
Upregulates CaSR expression
Calcitriol
Also expressed within the intestine, bone, kidneys, and calcitonin-secreting cells
CaSR
Can detect changes in Ca2+ content within the forming urine as well as the renal interstitium
Renal CaSR
Via CaSR activity, Ca2+ down-modulates proximal tubule expression of
CYP27B1
Mediates aspects of mono- and divalent cation transport which affect JG cell function, the urine concentrating mechanisms, and urinary acidification
Renal CaSR
Bioactive vitamin D (calcitriol) is biosynthesized from an inactive precursor that is produced in the
Skin (due to sunlight)
The formation of calcitriol is primarily stimulated by
PTH and hypophosphatemia
Functions to prevent hypocalcemia and hypophosphatemia
Calcitriol
The primary function of calcitriol is
Ca2+ and PO4 absorption from intestines
Intestinal Ca2+ and PO4 absorption are increased approximately 40% and 80%, respectively, in the
presence of
Calcitriol
Stimulates Ca2+ reabsorption and blocks PO4 secretion within the proximal tubule
Calcitriol
In the distal region of the nephron, calcitriol augments PTH-dependent
Ca2+ reabsorption
It has been shown that calcitriol can block PTH secretion. This effect is likely mediated by
Fibroblast growth factor 23
Secreted by the thyroid gland, and is a rapid-response hormone
Calcitonin
Calcitonin is secreted by
Parafolicular (C) Cells
Has been shown to exert an acute block in osteoclasts activity
Calcitonin
Impairs renal tubule Ca2+ reabsorption
Calcitonin
The Chronic actions of calcitonin appear to depress the formation of new osteoclasts, and this in turn blocks the differentiation of new
Osteoblasts
It appears that long term effects of calcitonin do not result in significant changes in
Serum Ca2+
Are there any long term pathologies associated with calcitonin excess in humans?
No
Calcitonin (nasal salmon calcitonin spray) is approved for the treatment of
Osteoporosis
You typically only use calcitonin spray for someone who can not tolerate
Antiosteoporotic agents (biphosphonates, estrogen replacement, and SERMs)
Produced by osteocytes and is a major determinant of PO4 homeostasis
Fibroblast growth factor 23 (FGF23)
A counter modulator of calcitriols effect on increasing plasma PO4
FGF23
Stimulated by hyperphosphatemia and calcitriol
FGF23 secretion
FGF23 binds to its cell surface receptor (FGFR), and binding of FGF23 to FGFR, as well as activation of FGFR are dependent upon in the presence of the co-receptor
Klotho
Blocks CYP27B1 expression
FGF23
Upregulates the activity of 24-hydroxylase
FGF23
Proximal tubule enzyme which converts calcitriol into an active metabolite
24-hydroxylase
Inhibits the proximal tubule PO4 pumps NaPi2a and NaPi2c
FGF23
Accommodate PO4 reabsorption within the proximal tubule
NaPi2a and NaPi2c
Lastly, FGF2 impairs secretion of
PTH
Exerts a number of effects on Ca2+ homeostasis and within bone tissue that collectively promote bone mineralization
Estradiol-17B (E2)
It has been demonstrated that E2 impairs PTH synthesis in post-menopausal women; however, parathyroid cells do not express either
ERa or ERB
Thus, the inhibitory effects of E2 on PTH secretion are most likely mediated via
FGF23
Recall that patients with chronic kidney disease can develop (secondary) hyperparathyroidism resulting in
Hyperphosphatemia
Has been independently associated with LVH in some CKD patients
FGF23